Nuclear Receptor Variants in Liver Disease

Publisher： Karger

E-ISSN： 1421-9875|33|3|415-419

ISSN： 0257-2753

Source： Digestive Diseases, Vol.33, Iss.3, 2015-05, pp. : 415-419

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease

By Yang Zhao-Xia  

Hepatology International, Vol. 4, Iss. 4, 2010-12 ,pp. : 741-748

Springer Publishing Company

Access to resources Recommend Favorite

Identifying Soluble Mediators of Nuclear Receptor and Insulin Signaling May Enhance Noninvasive Diagnosis of Fibrosis in Fatty Liver Disease

By  

Digestion, Vol. 90, Iss. 1, 2014-08 ,pp. : 33-34

Karger

Access to resources Recommend Favorite

Targeting Nuclear Bile Acid Receptors for Liver Disease

By  

Digestive Diseases, Vol. 29, Iss. 1, 2011-06 ,pp. : 98-102

Karger

Access to resources Recommend Favorite

Regulation of Liver Energy Balance by the Nuclear Receptors Farnesoid X Receptor and Peroxisome Proliferator Activated Receptor α

By  

Digestive Diseases, Vol. 35, Iss. 3, 2017-03 ,pp. : 203-209

Karger

Access to resources Recommend Favorite

Use of Farnesoid X Receptor Agonists to Treat Nonalcoholic Fatty Liver Disease

By  

Digestive Diseases, Vol. 33, Iss. 3, 2015-05 ,pp. : 426-432

Karger

Access to resources Recommend Favorite